Searched for
ACTIS BIOLOGICS
Domestic pharmaceutical players eye Bharat Serums acquisitionThe two funds together hold a 23% stake and the remainder is with the Daftary family.- Actis Biologics starts phase-III trials of cancer drugBiotech firm Actis Biologics today said that Angiozyme, its biotech molecule targeted at colorectal cancer has entered into the third phase...
- Actis Biologics to dilute stake to raise Rs 100 croreResearch-oriented technology incubator Actis Biologics is in talks with private equity (PE) players to dilute its stake in its two group en...
- Stocks to watch: Tata Motors, Hindalco, Strides Arcolab, Jubilant Organosys, Pratibha IndustriesTata Motors, the country's largest commercial vehicle maker, is exploring the possibility of buying the equity stake of private equity majo...
- Actis Biologics taps PE firms to raise Rs 125 crActis Biologics (India) is close to finalising a deal with private equity (PE) players to sell 15% stake.
- Indian Pharma Industry: In the pink of healthInnovation, international partnerships, collaborations, inflow of funds, clinical trials partnerships and co-development deals are changing...
- Hester Pharma's business by animal instinctHester Pharma makes vaccines for poultry that could prevent bird flu and other diseases.
- Actis signs pact to set up biotech city in MalaysiaActis has set up Malaysia Telesta Diagnostics centre focusing on computer-aided diagnosis for breast cancer. Telesta is also willing for a ...
Load More- Stocks to watch: Tata Motors, Hindalco, Strides Arcolab, Jubilant Organosys, Pratibha Industries